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Summary.-A series of257 cases of carcinoma of the male breast in Denmark during
the period from 1 January 1943 to 1 July 1972 has been reviewed, and a number of
clinical symptoms have been recorded and assessed.
Male breast carcinoma comprised 0-80' of all breast carcinomata in Denmark.
The average age was 65-2 years, which is considerably higher than in women. The
median duration of symptoms was 6 months. In only 130o was a palpable tumour
the single symptom present on referral. In 27o ulceration was found on admission.
However, ulceration was not, as commonly supposed, a particularly early mani-
festation of male breast cancer. It has been proved that ulceration is significantly
related to duration of symptoms and size of tumour. According to the TNM clas-
sification, 350' of 253 cases were in stage I, 11°o in stage II, 420% in stage III and
120 in stage IV. There was a significant correlation between the duration of
symptoms and the clinical stage, and the histological degree of malignancy and
the clinical stage. Expressed by the classification into stages, the clinical picture
was definitely more favourable on referral during the period 1958-72 than during
the period 1943-57.
MALE breast cancer is a rare disease.
According to most authors, the incidence
of male breast cancer is about 1% of all
breast cancers (Harnett, 1948; de Blois,
1963; Moss, 1964; W.H.O., 1971). From
-Africa, however, considerably higher inci-
dences have been reported: from 6-4 to
27.20/ (Davies, 1949; El-Gazaverli and
Abdel-Aziz, 1963; Bhagwandeen, 1972).
The largest original series of male
breast cancer have been published by
Williams (1889a, b)-100 cases; Sachs
(1941)-205 cases; Huggins and Taylor
(1955)-75 cases; Moss (1964)-507 cases;
Keller (1967)-181 cases: Holleb, Free-
man and Farrow (1968)-198 cases; Norris
and Taylor (1969)-113 cases. Many
smaller series, comprising from 5 to 40
cases, have been reported. Fifty-eight
Danish cases were presented bv Kappel-
gaard (1944).
The purpose of this studv is to in-
vestigate the clinical manifestations of
male breast cancer, on the basis of our
own material and on a review of the
literature.
MATERIAL A-ND METHODS
The material consists of 257 cases of
carcinoma of the male breast collected from
all over Denmark. using the files of the
DanishCancerRegistrvwhich wasestablished
in May 1942. It comprises all cases recorded
during the period from 1 January 1943 to
1 July 1972. Notification of cases is almost
complete from all over the country and the
series is therefore assumed to be unselected.
In a recent work the available histo-
logical preparations from 187 cases of the
present group were reviewed (Visfeldt and
Scheike. 1973). The oestradiol metabolism
was studied in 19 patients (Scheike. Sven-
strup and Frandsen. 1973). The association
between the Klinefelter syndrome and breast
cancer has been studied (Scheike. Visfeldt
and Petersen. 1973). Finally. the associa-
tion between gvnaecomastia and breastMAL BREAST CANCER
cancer has also been investigated (Scheike
and Visfeldt, 1973).
Ofthe 257 cases, 6 were not histologically
verified. Nevertheless, they have been in-
cluded because the clinical diagnosis and the
clinical course were unmistakable. These
6 patients died from the disease with wide-
spread metastases from 3 months to 2 years
and 10 months after establishment of the
diagnosis. In none of these cases was
autopsy performed. Eight cases of histo-
logically verified sarcoma of the breast were
excluded because of the rather special
clinical picture of breast sarcoma. The 257
patients were admitted to various hospitals
throughout the country, including the
Radium Centres in Copenhagen, Arhus and
Odense. One hundred and fifteen patients
were referred to these radium centres in
connection with the initial radiotherapy,
some primarily, others after surgical treat-
ment in other hospitals. It was possible
to obtain and review the original hospital
records for all 257 cases. One case has
been reported previously (West, 1952).
Some clinical manifestations of the
disease were recorded and evaluated by
approaching all surviving patients in Den-
mark and also by reviewing the hospital
records.
In the present study the conventional
chi-square test was used to assess whether
or not statistical dependence existed between
selected pairs of variables. In the tables
with n x 2 cells (n > 2) however, the
chi-square test described by Edwards (1958)
was used.
RESIULTS
Incidence
According to the Danish Cancer Regis-
try (Clemmesen, 1965, 1969), an average
of approximately 10 cases of male breast
carcinoma per year are seen in Denmark
from a population of about 4-5 million
in 1957. The total annual number of
new cases ranged from 1 (1961) to 20
(1956). In the years 1953-62, the annual
number of new cases averaged 11, as
against an average of 10 cases during the
entire period from 1943 to 1962. This
suggests that there has not been any
noticeable increase in the disease. Male
breast carcinoma comprised 0.8% of all
breast carcinomata (male and female).
The incidence in Denmark of male breast
cancer corresponds well with the results
found by most other authors (see above).
Age
Age specific incidence rates are shown
in Fig. 1. The youngest patient in the
series was 34 years old and the oldest,
90; the average age was 65-2 years.
Thirty-nine per cent were 70 years or
more at the time of diagnosis. Fig. 1
also illustrates the age specific incidence
rates for female breast cancer in Denmark.
Symptoms
Initial symptam.-Information about
the first symptom observed by the
patients was obtained in 255 cases (99%)
of the present series. Distribution of
the symptoms is shown in Table I. In
the present material a lump in the
TABLE I.-Initial Symptoms in 257 Cases
of Male Breast Carcinoma in Denmark,
1943-72
Initial symptoms
Lump
Pain and tenderness
Ulceration of skin of breast (excluding
nipple)
Nipple retraction
Eczema of the nipple
Nipple ulceration
Nipple itching
Nipple discharge (bloody)
Nipple discharge (other)
Generalized hardness of breast
Redness of skin
Axillary tumour
Swelling of arm
General symptoms due to distant
metastases
No symptoms, disease discovered at
physical examination
Total
Symptoms unknown
Total
Number of
patients
182 (710o)
19 (8%)
11 (40)
10 (40/)
2
6
2
6
3
1
1
4
1
2
5
255
2
257
breast was the first symptom observed
by the majority of patients (71%, Table
I). In most cases the patient discovered
the lump by accident, pain being the
first symptom in only 8% of the cases.
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FIG. 1.-Age specific incidence rates, breast cancer, men, Denmark 1943-72 and breast cancer
women, Denmark 1943-62. (Data for female breast cancer taken from Clemmesen, 1965, 1969.)
According to most authors, a painless
lump beneath the areola is the most
common initial symptom in carcinoma
of the male breast (Huggins and Taylor,
1955; Holleb et al., 1968). Nipple abnor-
mality was the initial symptom in 29
cases (11%). Nipple discharge as the
initial symptom was reported in only
9 (4%) of our patients. In 6 of the
cases (2%) the discharge wassanguineous.
Five patients (2%) had the tumour
detected bv chance during the course of
I- I
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a physical examination without any
symptoms being present.
TABLE II.-Duration of Symptoms-Male
Breast Carcinoma in Denmark, 1943-72
0/
,0
Duration of Number of Distribution
symptoms patients cumulated
<2 weeks 8 3
2 weeks-< month 17 10
1-<3 months 52 31
3-<6 months 18 38
6- <12 months 44 56
12- <24 months 41 73
24-< 36 months 26 84
36-<60 months 13 89
>,60 months 26 100
Total 245
Median duration of 6 months
symptoms
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Duration of symptoms.-The duration
of svmptoms before admission to hospital
is shown in Table II. Information was
obtained in 245 cases (950). The median
duration of symptoms was 6 months; the
duration varied from a few days to as
much as 20 years. In nearly all cases
the patients themselves were responsible
for the delay. In other series of male
breast cancer (Moss, 1964; iHolleb et al.,
1968) the median duration of syNmptoms
was 5 months and 7 months respectively.
Between 1943 and 1957 the median
duration of symptoms was 6 months,
and between 1958 and 1972 it was 7-5
months. Hence, the median duration of
symptoms had increased slightly during
1957
1972
1 3 6 9 12 18 24 60 1:
DURATION OF SYMPTOMS IN MONTHS
FIG. 2.-Cumulative distributions of duration of svmptoms in male breast cancer in Denmark
1943-57 and 1958-72. The scale for duration of svmptoms is compressed in the period from
24 to 120 months.
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the last 15 years in this country. Graphs
of the separate cumulative distributions
in the two periods are shown in Fig. 2.
Symptoms on admi88ion.-On admis-
sion to hospital, 136 patients had cancer
of the left breast and 120 of the right.
One patient developed a new primary
cancer in the opposite breast 9! years
after diagnosis of the first one. The
ratio of left-sided involvement to right-
sided was 1-13; this predominance of the
left-sided cases is not, however, statistic-
ally significant (P > 0-05, binomial test
with equal probabilities). Both in male
and female breast cancer predilection for
the left side has been found. In 1158
patients with male breast cancer, col-
lected from the literature (Chrichlow,
1972) 590 were left-sided and 552 right-
sided, corresponding to a ratio of 1-07.
Sixteen (1-4%) of the 1158 cases were
synchronously or metachronously bilat-
eral. Busk and Clemmesen (1947) studied
the incidence of left-sided and right-
sided female breast cancer in the records
of the Danish Cancer Registry from 1942
to 1946: 2117 tumours were localized to
the left and 1908 to the right breast,
the ratio ofleft-sided disease toright-sided
being 1 11.
All palpable tumours were located in
the central part ofthe breast, immediately
beneath the nipple and the areola, or,
as far as the large tumours were con-
cerned, with the centre in this area.
Information on tumour size was obtained
in 239 cases (93%). Table III shows the
distribution of tumours according to size.
They varied from a diameter of 1-28 x 16
cm. Furthermore, Table III illustrates
the relationship between size of tumour
and ulceration, and size of tumour and
duration of symptoms. In the present
material the frequency of ulcerations
increased significantly with increasing
size of tumour (P < 04001, chi-square
test for trend, Edwards, 1958). There
was also a significant relationship between
duration of symptoms and size of tumour
(P < 0.05). Hence, when symptoms had
been present for less than 3 months, the
diameter of the tumour was more than
3 cm in 3400, whereas tumours with a
duration of svmptoms of 12 months or
more had a diameter exceeding 3 cm in
570o of cases. A similar relationship
between duration of symptoms and size
of tumour was found in female breast
cancer (Bloom, 1965; Haagensen, 1972).
The other signs and symptoms on
admission to hospital are shown in
Table IV. It appears that in only 13%
was a palpable tumour the only symptom
present on referral. In all other cases
the tumour was associated with more or
less severe signs of clinical advancement.
Nipple abnormalities were seen frequently,
Hence, nipple retraction occurred in 3300
and ulceration of the nipple in 16%.
Nineteen patients (8%) presented nipple
discharge on referral or earlier. Three
of these patients had bloody discharge
on referral and a total of 11 patients
(4%) had bloody discharge on referral
or earlier. Skin fixation was present in
44% of cases. In 30% of cases it was
of an incomplete nature, i.e., tethered or
dimpled skin without tumour infiltration.
Ulceration was a frequent symptom.
Twentv-seven per cent of our cases
TABLE III.-Tumour Size Related to Ulceration and Duration ofSymptoms
Duration ofsymptoms
Ulcerated A
tUrmours <3 months 3-11 months > 12 months
Tumour A---_
size No. % No. °/0 No °00 No. O/ No. 0h
<2cm 58 24 6 10 26 36 13 21 19 18
>2-3cm 64 27 12 19 22 30 16 26 26 25
>3-4 cm 51 22 17 33 15 21 9 15 27 25
>4-5 cm 27 11 7 26 4 6 7 12 16 15
>5 cm 39 16 23 59 5 7 16 26 18 17
Total 239 100 72 100 61 100 106 100
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TABLE IV.-Signs and Symptoms on Ad-
mission to Hospital
Svmptoms
Lu-imp in breast only
Lamp in breast plus:
Nipple retraction
Nipple ulceration
Nipple discharge (bloody in one case)
Skin fixation /incomplete Icomplete
Ulceration
Fixation to pectoral fascia or pectoral
muscle
Chest wal fixation
Local pain and tenderness
Palpable regional axillary nodes
Palpable homolateral supraclaVicular
nodes
Distant metastases
General symptoms due to distant
metastases
Bloody nipple discharge only
No symptomatology known
No. %
34 13
84 33
40 16
3 1
76 30
36 14
67 27
43 17
13 5
33 13
100 40
6 2
29 12
16 6
2 1
4 2
presented ulceration on referral. In 22%
the tumour was attached to the under-
lying tissue. In 1700 the tumour was
attached to the pectoral fascia or muscle.
In 500 fixation to the chest wall was
noted. Huggins and Taylor (1955) ob-
served fixation to underlying tissue in
30%0 of their cases. Local pain and
tenderness seem to occur very late, and,
surprisingly enough, it was present in
very few cases in view of the fact that
there was ulceration in 27% in our series.
In 100 cases (40%o) palpable regional
lymph nodes in the axilla were present.
There was generally no indication as to
whether or not the nodes were considered
to contain growth. In 24 of these cases
(24%) the palpable regional axillary
nodes were fixed to each other or to other
structures. In one case the nodes were
ulcerated. In a review from the litera-
ture, 474 male patients, or 54% of
the 873 patients suitable for review,
had clinical axillary node involvement
(Chrichlow, 1972).
TNM stage
On review ofthe records it was possible
to define the clinical stage of advance-
ment on admission to hospital in 253
cases. The staging was done according
to the TNM classification (U.I.C.C. pub-
lication, 1968). The result is shown in
Table V. It will be seen that stage I,
350o of cases, and stage III, 42%, were
predominant. The frequency ofstage Ill
TABLE V.-Clinical Stage of Advancement
on Admission to Hospital According to
Period of Diag7nosi (TNM Clawifica-
tion)
TNM
stage
I
II
m
IV
Total
Unknown
1943-72
No. 0/
89 35
28 11
107 42
29 12
253 100
4
1943-57
No. 0
31 26
16 13
51 43
22 18
120 100
1
1958-72
No. ,O
58 44
12 9
56 42
7 5
133 100
3
is not surprising since a fairly high per-
centage of the tumours was completely
fixed to the skin, ulcerating or fixed to
underlying tissue. By combining the
results from four series of male breast
carcinoma, distributed into stages accord-
ing to the TNM classification (Sinner,
1961 (27 cases); de Blois, 1963 (49 cases);
Greening and Aichroth, 1965 (28 cases),;
Rissanen, 1968 (40 cases)), the following
distribution was observed in a total of
144 cases: stage I= 32%, stage =_ 19%,
stage III =35%, and stage IV= 14%.
This distribution is very similar to that
found in the present series. Table V
illustrates also the changes in clinical
stage occunring between the periods 1943-
57 and 1958-72. There is a statistically
significant correlation between clinical
stage and period ofdiagnosis (P < 0.001).
The table shows that, in the period
1943-57, stage I amounted to 26%
whereas in the period 1958-72 it had
increased to 44%.
MIultiple primary cancer
Twenty-six patients had an associated
primary cancer arising in another ana-
tomical site; the incidence of a second
primary cancer was 10%. The distribu-
tion is shown in Table VTI. Holleb et
oaaOLE SCHEIKE
al. (1968) found an incidence of 7-50
among 198 cases of male breast cancer.
TABLE VI.-Multiple Primary Cancers in
257 Mlale Breast Cancer Patients
Second primary diagnosed
Before breast cancer
Basal cell carcinoma of the skin
Fibromvxosarcoma
Cancer of the hypophanx
Simultaneous with breast cancer
Basal cell carcinoma of the skin
MNultiple myeloma
Subsequent to breast cancer
Gastric cancer
Duodenal cancer
Colonic cancer
Rectal cancer
Prostatic cancer
Carcinoma of the bladder
Lung cancer
Lymphatic leukaemia
Reticulosarcoma
Glioblastoma
Total
No. of
cases
3
1
1
2
1
5
1
1
2
3
1
1
2
1
1
26 (boo0)
DISCUSSION
Male breast cancer is a disease of
elderly men. The average age at diag-
nosis seems to have increased graduallv:
Williams (1889)-50 years; Sachs (1941)-
57-2 vears; Moss (1964)-64 years; Keller
(1967)-65 years; present series-65-2
vears. This is probably due to the fact
that the percentage of old men in the
population has increased with time.
Average ages reported in series of male
breast cancer from certain parts of Africa
are exceptions to this rising trend in
average age with time. In these series
average ages as low as 41 years have been
reported (El-Gazayerli and Abdel-Aziz,
1963; Bhagwandeen, 1972). Comparison
with African series is complicated by the
fact that African men aged over 50
often feel that life is over and do not
bother to seek medical treatment for
fatal diseases. The average age of 65 2
years in the present series is distinctfl
higher than the average age in series of
female breast carcinoma, and all authors
agree that carcinoma of the male breast
occurs at a later age than carcinoma of
the female breast.
In view ofthe sparsity of breast tissue
in the male, it might be expected that
breast cancer would be discovered earlier
than in the female; this is not the case.
In the present series the diagnosis was
established within 1 vear in 5600 and
within 2 years in 73%' of cases. In
16% the duration of syNmptoms was 3
years or more (Table II). In Bloom's
(1965) the Haagensen's (1972) series of
female breast cancer, the diagnosis was
established within 1 year in 82% and
90 20 respectively and within 2 vears
in 91% and 94 5%/ respectively. In 5%
and 3.4% respectively the duration of
svmptoms was 3 vears or more. The
main cause of this longer delay in the
male is probably the ignorance of the
possibility of such a lesion, a lack of
" breast consciousness ".
The central location ofthe tumour and
the sparsity of breast tissue make nipple
abnormality a frequent syamptom in male
breast cancer. Thus, nipple retraction
was found by Sachs (1941) in 33%/' of
205 cases and by Holleb et al. (1968) in
3300, these results being in good agree-
ment with those found in our series.
Our figures for nipple discharge (8%)
and bloody discharge (4%) are lower than
those reported by Treves, Robbins and
Amoroso (1956): out of 131 males with
breast cancer, 18 (14%) had nipple dis-
charge, and it was occasionally bloody in
15a cases (11%). Out of 577 males with
benign breast tumours only 12 (2%) had
nipple discharge and only 4 (0-70o) pre-
sented bloodv discharge. Norris and
Taylor (1969) found nipple discharge in
26% of their 105 cases. Sachs (1941)
found bloody discharge in 15% of his
cases. Nipple discharge, and in parti-
cular bloody discharge, must thus be
considered a much more serious clinical
sign in males than in females. In the
latter, nipple discharge will often be
caused by benign intraductal papillomata
(Andersen and Koudal, 1965: Buhl-
J0rgensen et al., 1968).
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All authors agree that ulceration
occurs more frequentlv in male breast
cancer than in female. In 26% of
Sachs' material and in 18% of Norris and
Tavlor's cases ulceration was present.
Some authors maintain that ulceration
is independent of duraton of symptoms
and size of tumour, and that it occurs
earlv in the male because of the close
vicinity to the skin (Wainwright, 1927:
Gilbert, 1933: Sachs, 1941; Huggins and
Tavlor, 1955). In the present series the
frequency of ulcerations increased signifi-
cantly with increasing size of tumour
(P < 0-001, Table III). Furthermore, the
ulceration was significantly related to
duration of symptoms (P < 0-001, Table
III). Hence, in only 110% of the ulcer-
ated tumours was the duration of symp-
toms below 6 months, as against 49%0
of those without ulceration. In 60% of
the ulcerated tumours the duration of
symptoms was one vear or more, as
against 38% of those without ulceration
(Table V7II). Furthermore, ulceration was
the initial symptom in only 60% of the
cases (Table I), whereas it was found in
27% of the cases on admission (Table
IV). Hence, in the present series ulcera-
tion appears to be a late svmptom.
A similar correlation has been found
for tumours fixed to underlying tissue
and duration of symptoms (P < 0.01).
Out of 54 fixed tumours and 191 non-
fixed tumours with a known duration of
symptoms, only 17% ofthe fixed tumours
presented a duration of symptoms of less
than 6 months, as against 44%/ of the
non-fixed. Fiftv-three per cent of the
fixed tumours had a duration ofsymptoms
ofone year or more, as against 42% ofthe
non-fixed.
Two factors seem to influence the
clinical stage of the present material. In
our series a significant correlation
(P < 0-001) has been found between
duration of symptoms and clinical stage
on admission (Table VIII). Hence, the
table shows that 58% of the patients in
clinical stage I had a duration ofsymptoms
of less than 6 months, as against only
25% of the stage III patients and 27 %
of the stage IV, patients. Onlv 140% of
the patients in clinical stage I had a
duration of svmptoms of 2 years or
more, as against 370o of stage III patients
and 31% of stage IV patients. Another
factor influencing the stage on admission
is the histological grade of malignancy.
It was possible to grade the histological
preparations from 150 cases ofthe present
material. In Table IX these two factors
TABLE VII.-Duration ofSymptooms in Non-ulcerated and Ulcerated MIale M3lammary
Carcinoma
Duration of symptoms in months
<3 3-5 6-11 12-35 336
No. N. 0°o No. 0 No. 0O No. 0l No. ° o
Non-ulcerated tumours 180 64 36 23 13 24 13 42 23 27 15
Ulcerateed tumours 65 4 6 3 5 19 29 26 40 13 20
TABLE VIII.-Clinical Stage of Advancement and Duration ofSymptoms
Duration of symptoms in months
T-NM
stage
I
II
m
IV
No.
87
26
0O0
29
<3
NO. 00
44 50
10 39
17 17
a 17
3-5
NO. 0
7 8
2 8
8 8
3 10
6-11
N-O. 0
13 15
3 11
16 16
10 35
12-23
-No. 0O
11 13
5 19
92 22
2 7
24-35
No. o0
7 8
3 11
16 16
4 14
36
-No. 01
5 6
3 11
21 21
5 17
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TABLE IX.-Histological Grade and Clinical Stage of Advancement
Clinical stage of advancement
I II III IV
Histological Stage
grade No. No. % No. No. % No. % unknown
I 44 24 55 2 4 18 41 0 0 0
II 81 25 32 9 12 38 49 5 7 4
III 25 7 28 3 12 12 48 3 12 0
are presented in relation to one another.
By comparing histological grade of malig-
nancy and clinical stage, a significant
correlation was found between these
two factors (P < 005). (During the sta-
tistical test, stages II, III and IV were
added up and assessed against stage I.)
Hence, 55% of the turnours of grade I
were of clinical stage I, as against 45%O
of stages II + III + IV. Twenty-eight
per cent of the tumours of grade III were
of clinical stage I, as against 72% of
stage II + III + IV.
The male patient with breast cancer
does not appear for diagnosis and treat-
ment until unequivocal clinical signs of
malignancy have made him suspicious.
On the whole, male breast carcinoma will
present more distinct clinical signs than
those seen in the female because of the
advanced stage. Hence, only during the
early stages will there be certain differ-
ential diagnostic problems in male breast
cancer. Attempts should be made to
differentiate the disease from gynaeco-
mastia, which is much more frequent.
In males beyond young adult life, clinical
gynaecomastia is far from rare, the
maximum frequency occurring at the age
of 50-60 years (Sirtori and Veronesi,
1957). In cases of gynaecomastia, J//s-
kelainen (1951) found skin fixation of
tumour in 65%, fixation to underlying
tissue in 77% and nipple retraction in
2%. Payson and Rosh (1949) found
skin fixation in 44°/ of benign breast
tumours in men.
My thanks are due to Mr J. Nyboe,
Cand.Act., statistician at Rigshospitalet,
Copenhagen, for his critical review of the
statistical calculations. The study was
supported by a grant from the National
Anti-cancer League.
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